DIRECTORS AND SENIOR MANAGEMENT

strategy, and business development leadership roles for Pfizer, Inc.’s pharmaceutical business across
a variety of international regions and markets, including Asia, Eastern Europe, and Latin America. Mr.
Krishana was at Pfizer from 2003 to 2007 and from 2008 to 2011. From 2008 to 2010, Mr. Krishana
was based in Beijing, China, where he served as a Senior Director and a member of the Pfizer China
Leadership Team. Mr. Krishana began his career as a strategy consultant at Accenture plc.

Mr. Krishana received a B.A. in Economics and Political Science from Brown University in May,

1995, and a Masters of Public Policy from Harvard University in June, 2011.

Mr. Thomas Malley, aged 49, has served as a member of our Board since January 2016. Mr.
Malley has served as a director of BeiGene Beijing since 2016. Mr. Malley has served as president of
Mossrock Capital, LLC, a private investment firm, since May 2007. Mr. Malley worked for Janus
Mutual Funds in positions of increasing responsibility from April 1991 to May 2007. From January
1999 to May 2007, Mr. Malley served as the portfolio manager of the Janus Global Life Sciences Fund
and also led the Janus healthcare team of analysts. From 1991 to 1998, Mr. Malley served as an equity
analyst for Janus covering, among others, healthcare and biotechnology stocks. Mr. Malley received
a B.S. in Biology from Stanford University in January 1991.

Mr. Malley has held directorships in the following listed companies:

•

•

•

•

•

•

Kura Oncology, Inc., a company listed on the Nasdaq, as a director since 2015;

Kiniksa Pharmaceuticals, a company listed on the Nasdaq, as a director since 2016;

OvaScience, Inc., a company listed on the Nasdaq, as a director from 2012 to 2017;

Synageva BioPharma Corp., a Company listed on the Nasdaq prior to its delisting in May
2015 in connection with the sale of the company, as a director from 2006 to 2015;

Puma Biotechnology, Inc., a company listed on the Nasdaq, as a director from 2011 to 2015;
and

Cougar Biotechnology, Inc., a company listed on the Nasdaq prior to its delisting in July
2009 in connection with the sale of the company, as a director from 2007 to 2009.

Mr. Jing-Shyh (Sam) Su, aged 66, has served as a member of our Board since April 2018. Mr.
Su retired from Yum! Brands, Inc., a company listed on the New York Stock Exchange (“Yum!
Brands”), in May 2016, where he served as Vice Chairman of the Board, and was the Chairman and
CEO of the company’s China division. During Mr. Su’s 26 years with Yum! Brands, its China division
grew from just four restaurants to over 7,000 to become the largest multinational restaurant chain in
China, contributing more than half of Yum! Brands’ world-wide revenues in 2015. Mr. Su started his
career with Yum! Brands in 1989 as KFC International’s director of marketing for the North Pacific
region. In 1993, he became vice president of North Asia for both KFC and Pizza Hut. Mr. Su was
named president of Greater China for Tricon Global Restaurants International upon Pepsi’s spin-off
of the restaurant business in 1997. Before joining Yum! Brands, Mr. Su worked with Procter & Gamble
in Germany and Taiwan.

— 325 —

